BioSpace News Archive

Pharm Country

CytoSorbents To Expand Direct Sales of CytoSorb® to the United Kingdom, the Sixth Largest Medical Device Market in the World

CytoSorbents Corporation announces that it has registered a new subsidiary, CytoSorbents Medical UK Limited, with plans to establish a direct sales presence.

April 14, 2022
·
7 min read
International Neuromodulation Society Announces “Innovations in Neuromodulation” Educational Event at INS World Congress

In “Innovations in Neuromodulation,” the International Neuromodulation Society (INS) brings together industry leaders, innovators and investors May 22 to discuss commercialization from a global perspective.

April 14, 2022
·
2 min read
Business

Editas Medicine Appoints Gilmore O’Neill as Chief Executive Officer

Editas Medicine, Inc. today announced that its Board of Directors has appointed Dr. Gilmore O’Neill, M.B., M.M.Sc., as President and Chief Executive Officer.

April 14, 2022
·
5 min read
Biotech Bay

Allogene Therapeutics Unveils Cell Forge 1, a Uniquely Designed Manufacturing Facility to Deliver AlloCAR T™ Products

Allogene Therapeutics, Inc., a clinical-stage biotechnology company pioneering the development of allogeneic CAR T products for cancer, announced the virtual unveiling of its manufacturing facility, Cell Forge 1, located in Newark, California.

April 14, 2022
·
5 min read
Lone Star Bio

Moleculin Announces Corporate Rebranding and Launch of New Website

Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, today announced the launch its new corporate branding and website www.moleculin.com.

April 14, 2022
·
4 min read
Edgewise-Funded Natural History Trial of Becker Muscular Dystrophy (BMD) Now Enrolling

Edgewise Therapeutics, Inc. today announced the initiation of an Edgewise-funded observational trial in individuals with BMD.

April 14, 2022
·
9 min read
Drug Development

Magenta Therapeutics Focuses R&D and Operational Spending, Reduces Workforce and Extends Cash Runway

Magenta Therapeutics Focuses R&D and Operational Spending, Reduces Workforce and Extends Cash Runway.

April 14, 2022
·
6 min read
Business

Horizon Therapeutics plc to Release First-Quarter 2022 Financial Results and Host Webcast on May 4, 2022

Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it will release its first-quarter 2022 financial results on Wednesday, May 4, 2022.

April 14, 2022
·
1 min read
BioMidwest

Forge Biologics to Present at Chardan’s 6th Annual Genetic Medicines and Cell Therapy Manufacturing Summit

Forge Biologics to Present at Chardan’s 6th Annual Genetic Medicines and Cell Therapy Manufacturing Summit.

April 14, 2022
·
1 min read
Deals

Midatech Pharma PLC Announces Receipt of NASDAQ Notice

Midatech Pharma PLC announces that it received written notification from The NASDAQ Stock Market LLC dated 13 April 2022, stating that the Company is not in compliance with the minimum bid price requirement set forth in NASDAQ’s rules.

April 14, 2022
·
6 min read